Health Care · Electromedical & Electrotherapeutic Apparatus · Nasdaq · CIK 1844505 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $2.70Day −0.37%Mkt cap $33M1Y −54.9%Off 52W high −64.5%Vol (1Y) 78.1%
Daily closing price, split-adjusted to the current basis; 1.5y shown of 384 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest1.6% of sh out |
| Days to cover13.6d |
| Top-10 13F concentration98.4% |
| Next report (est.)2026-08-13 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$18.9M |
| Earnings (TTM)-$21.1M |
| Net margin−111.4% |
| ROIC−130.7% |
| Debt / equity1.57× |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−70.0% |
| 1Y−54.9% |
| Since incept. (ann.)−56.8% |
Total return through 2026-07-30 · series begins 2024-03-05. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)78.1% |
| Ann. volatility (3Y)128.8% |
| Sharpe (1Y)−1.79 |
| Sharpe (3Y)−0.40 |
| Max drawdown (1Y)−65.1% |
| Max drawdown (3Y)−87.4% |
| Beta (3Y vs SPY)−1.04 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Lynrock Lake LP | 1.2M | $7M | 9.59% | new |
| Alyeska Investment Group, L.P. | 702,776 | $4M | 5.84% | new |
| Bleichroeder LP | 166,666 | $978,329 | 1.38% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 141,780 | $832,608 | 1.18% | new |
| MILLENNIUM MANAGEMENT LLC | 70,144 | $411,745 | 0.58% | new |
| BlackRock, Inc. | 28,344 | $166,379 | 0.24% | new |
| Blue Trust, Inc. | 23,998 | $140,868 | 0.20% | new |
| VANGUARD CAPITAL MANAGEMENT LLC | 21,926 | $128,706 | 0.18% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2025-12-31 | 2026-03-25 | — | — | $8.3M | +877.2% |
| 2025-09-30 | 2025-11-10 | — | — | $4.2M | +338.5% |
| 2025-06-30 | 2025-08-07 | — | — | $3.7M | +113.5% |
| 2025-03-31 | 2025-05-13 | — | — | $2.8M | +105.4% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-13 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
Reportable 100%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
